دورية أكاديمية

Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

التفاصيل البيبلوغرافية
العنوان: Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia
المؤلفون: Qi Zhang, Bridget Riley-Gillis, Lina Han, Yannan Jia, Alessia Lodi, Haijiao Zhang, Saravanan Ganesan, Rongqing Pan, Sergej N. Konoplev, Shannon R. Sweeney, Jeremy A. Ryan, Yulia Jitkova, Kenneth Dunner, Shaun E. Grosskurth, Priyanka Vijay, Sujana Ghosh, Charles Lu, Wencai Ma, Stephen Kurtz, Vivian R. Ruvolo, Helen Ma, Connie C. Weng, Cassandra L. Ramage, Natalia Baran, Ce Shi, Tianyu Cai, Richard Eric Davis, Venkata L. Battula, Yingchang Mi, Jing Wang, Courtney D. DiNardo, Michael Andreeff, Jeffery W. Tyner, Aaron Schimmer, Anthony Letai, Rose Ann Padua, Carlos E. Bueso-Ramos, Stefano Tiziani, Joel Leverson, Relja Popovic, Marina Konopleva
المصدر: Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-1 (2022)
بيانات النشر: Nature Publishing Group, 2022.
سنة النشر: 2022
المجموعة: LCC:Medicine
LCC:Biology (General)
مصطلحات موضوعية: Medicine, Biology (General), QH301-705.5
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2059-3635
Relation: https://doaj.org/toc/2059-3635
DOI: 10.1038/s41392-022-00958-4
URL الوصول: https://doaj.org/article/0bea0028687644349367928f6f176be8
رقم الأكسشن: edsdoj.0bea0028687644349367928f6f176be8
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20593635
DOI:10.1038/s41392-022-00958-4